Inventor
FOGUET RAFAEL
ES27 patents
⚠️ This page may combine multiple inventors who share the name “FOGUET RAFAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FERRER INT
26 patentsUS5665736ASep 9, 1997
N-benzoylmethyl-piperidines
FERRER INT8 citations72
US5395841AMar 7, 1995
4-benzylpiperidines for treating phychosis
FERRER INT12 citations72
US4883797ANov 28, 1989
Derivatives of piperazine, method for making the same
FERRER INT10 citations72
US4859675AAug 22, 1989
1-[2-(phenylmethyl) phenyl]piperazines as antidepressants
FERRER INT12 citations72
US5939555AAug 17, 1999
Polymorphs B and C of 1- 2,4-dichloro-β- (7-chlorobenzo b!thien-3-yl)methoxy!phenethyl!imidazole mononitrate
FERRER INT10 citations68
US6881845B2Apr 19, 2005
Process for preparing (±)trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine
FERRER INT8 citations67
US5135943AAug 4, 1992
1H-imidazole derivative compounds and pharmaceutical compositions containing the same
FERRER INT12 citations67
US6187793B1Feb 13, 2001
7-[(Piperidin-1-YL)-Propoxy]-chromen-4-one derivatives, their preparation and their pharmaceutical use
FERRER INT2 citations61
US4767767AAug 30, 1988
2-pyrrolidinylethyl-2-(7-trifluoromethyl-4-quinolyl-aminobenzoate having analgesic, antipyretic and anti-inflammatory activities
FERRER INT2 citations61
US4535159AAug 13, 1985
Process for producing 1-position amino-derivatives of 1-(3',4'-methylenedioxyphenyl)propane-2-ol
FERRER INT5 citations61
US5736558AApr 7, 1998
4-(6-fluoro-1,2-benzisoxazolyl)-1 piperidinyl-propoxy-chromen-4-one-one-derivatives, their preparation and their use in the treatment of psychosis, schizophrenia and anxiety
FERRER INT4 citations60
US4610998ASep 9, 1986
Imidazolylethoxyindanes and use as antithrombotic agents
FERRER INT5 citations60
US5973155AOct 26, 1999
Process for preparing (-)-trans-N-p-fluorobenzoylmethyl-4-(p-fluorophenyl)-3-[[3,4-(methylened ioxy)phenoxy]methyl]-piperidine
FERRER INT2 citations59
US5643927AJul 1, 1997
4-p-fluorobenzoyl-1-piperidinyl-propoxy-chromen-4-one derivatives, their preparation and their use in the treatment of psychosis and schizophrenia
FERRER INT4 citations59
US7635691B2Dec 22, 2009
Use of CDP-choline for the prophylactic treatment of cerebral ischemia
FERRER INT2 citations58
US6930096B2Aug 16, 2005
Use of CDP-choline for the prophylactic treatment of cerebral ischemia
FERRER INT4 citations58
US4728655AMar 1, 1988
Sulfonamidines, process for the production thereof and pharmaceutical compositions containing the same
FERRER INT3 citations58
US4719225AJan 12, 1988
Thiophene ring-substituted α-(alkylaminopropionyl)-thiophenes and the method for preparing the same
FERRER INT0 citations51
US6348605B1Feb 19, 2002
Process for preparing 3-hydroxymethyl chromen-4-ones
FERRER INT0 citations50
US5798361AAug 25, 1998
5H-thiazolo 3,2-a!pyrimidin-5-one derivatives
FERRER INT0 citations50
US4843165AJun 27, 1989
Process for preparing a 2,3-dihydro-1H-imidazolyl-ethoxy indene antithrombotic agent and its pharmaceutically acceptable salts
FERRER INT1 citations50
US6005115ADec 21, 1999
Forms A and B of N-[[[2-[[[2-[(diaminomethylene)amino]-4-thiazolyl]methyl ]thio]ethyl]ami no]methylene]-4-bromo-benzenesulfonamide
FERRER INT0 citations48
US4603134AJul 29, 1986
Piperazine derivative and pharmaceutical composition containing the same
FERRER INT1 citations48
US4600780AJul 15, 1986
N-cyano-formamidines
FERRER INT1 citations48
US6894032B2May 17, 2005
Use of CDP-choline for the treatment of alcohol withdrawal syndrome
FERRER INT0 citations45
US7205405B2Apr 17, 2007
Process for preparing 3-(2-(4-(6-fluorobenzo(d)isoxazol-3-yl)-piperidin-1-yl)-ethyl)-2-methyl- 6,7,8,9-tetrahydro-4h-pyrido-(1,2-a)pyrimidin-4-one
FERRER INT0 citations31